ZA931773B - Substituted phenylacetamides. - Google Patents

Substituted phenylacetamides.

Info

Publication number
ZA931773B
ZA931773B ZA931773A ZA931773A ZA931773B ZA 931773 B ZA931773 B ZA 931773B ZA 931773 A ZA931773 A ZA 931773A ZA 931773 A ZA931773 A ZA 931773A ZA 931773 B ZA931773 B ZA 931773B
Authority
ZA
South Africa
Prior art keywords
substituted phenylacetamides
phenylacetamides
substituted
Prior art date
Application number
ZA931773A
Other languages
English (en)
Inventor
Ulrich E Dr Mueller
Matthias Dr Mueller-Gliemann
Juergen Dressel Ph D
Peter Dr Fey
Rudolf Dr Hanko
Walter Dr Huebsch
Thomas Dr Kraemer
Martin Dr Beuck
Stanislav Prof Dr Kazda
Stefan Dr Wohlfeil
Oezkan Dr Yalkinoglu
Andreas Dr Knorr
Johannes-Peter Dr Stasch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA931773B publication Critical patent/ZA931773B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA931773A 1992-03-13 1993-03-12 Substituted phenylacetamides. ZA931773B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4208051A DE4208051A1 (de) 1992-03-13 1992-03-13 Substituierte phenylessigsaeureamide

Publications (1)

Publication Number Publication Date
ZA931773B true ZA931773B (en) 1993-09-29

Family

ID=6453994

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931773A ZA931773B (en) 1992-03-13 1993-03-12 Substituted phenylacetamides.

Country Status (18)

Country Link
US (1) US5352687A (fi)
EP (1) EP0560163A1 (fi)
JP (1) JPH0616646A (fi)
KR (1) KR930019633A (fi)
CN (1) CN1076443A (fi)
AU (1) AU654427B2 (fi)
CA (1) CA2091434A1 (fi)
CZ (1) CZ29793A3 (fi)
DE (1) DE4208051A1 (fi)
FI (1) FI931089A (fi)
HU (1) HUT64040A (fi)
IL (1) IL104999A0 (fi)
MX (1) MX9301125A (fi)
NO (1) NO930760L (fi)
NZ (1) NZ247127A (fi)
SK (1) SK18793A3 (fi)
TW (1) TW223632B (fi)
ZA (1) ZA931773B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576342A (en) * 1992-03-13 1996-11-19 Bayer Aktiengesellschaft Phenylglycinamides of heterocyclically substitued phenylacetic acid derivatives
DE4309968A1 (de) * 1993-03-26 1994-09-29 Bayer Ag Phenylglycinamide von heterocyclisch substituierten Phenylessigsäurederivaten
DE4212796A1 (de) * 1992-04-16 1993-10-21 Bayer Ag Propenoyl-imidazolderivate
DE4302957A1 (de) * 1993-02-03 1994-08-04 Bayer Ag Imidazolyl-substituierte Phenylessigsäureprolinamide
DE19525028A1 (de) * 1995-07-10 1997-01-16 Bayer Ag Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
DE19535504A1 (de) * 1995-09-25 1997-03-27 Bayer Ag Substituierte Xanthine
DE19536378A1 (de) * 1995-09-29 1997-04-03 Bayer Ag Heterocyclische Aryl-, Alkyl- und Cycloalkylessigsäureamide
DE19546918A1 (de) * 1995-12-15 1997-06-19 Bayer Ag Bicyclische Heterocyclen
DE19546919A1 (de) * 1995-12-15 1997-06-19 Bayer Ag N-Heterocyclisch substituierte Phenylessigsäure-Derivate
US6774236B1 (en) 1996-04-04 2004-08-10 Bayer Aktiengesellschaft Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2A]indolcarbocyclic acids and their activated derivatives
DE19613549A1 (de) * 1996-04-04 1997-10-09 Bayer Ag Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
DE19613550A1 (de) * 1996-04-04 1997-10-09 Bayer Ag Neue Pyrimido[1,2-a]indole
EP0802192A1 (de) * 1996-04-17 1997-10-22 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
DE19619950A1 (de) 1996-04-17 1997-10-23 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide
US6465502B1 (en) 1998-12-23 2002-10-15 Novartis Ag Additional therapeutic use
RU2001114518A (ru) * 1999-09-29 2003-04-20 Орто-Макнейл Фармасьютикал, Инк. (Us) Изонипекотамиды для лечения опосредованных интегринами нарушений
US6987131B1 (en) 2000-06-26 2006-01-17 Burzynski Stanislaw R Phenylacetic acid compositions for treating or preventing hypercholesterolemia
UA75093C2 (en) 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
DE3800785A1 (de) * 1988-01-09 1989-07-20 Hoechst Ag Substituierte 7-(pyridazin-5-yl)-3,5-dihydroxyheptan(en)- saeuren, ihre entsprechenden (delta)-lactone bzw. derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
US5164407A (en) * 1989-07-03 1992-11-17 Merck & Co., Inc. Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
US5183810A (en) * 1990-02-13 1993-02-02 Merck & Co., Inc. Imidazole angiotensin II antagonists incorporating a substituted benzyl element
JPH05504359A (ja) * 1990-02-13 1993-07-08 メルク・エンド・カムパニー・インコーポレーテツド 置換ベンジル部分を含むイミダゾールアンギオテンシン２拮抗物質
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate

Also Published As

Publication number Publication date
CA2091434A1 (en) 1993-09-14
IL104999A0 (en) 1993-07-08
AU3402693A (en) 1993-09-16
TW223632B (fi) 1994-05-11
NO930760D0 (no) 1993-03-02
SK18793A3 (en) 1993-10-06
US5352687A (en) 1994-10-04
AU654427B2 (en) 1994-11-03
MX9301125A (es) 1993-09-01
CN1076443A (zh) 1993-09-22
JPH0616646A (ja) 1994-01-25
FI931089A (fi) 1993-09-14
FI931089A0 (fi) 1993-03-11
HU9300721D0 (en) 1993-05-28
NZ247127A (en) 1994-09-27
NO930760L (no) 1993-09-14
CZ29793A3 (en) 1994-01-19
HUT64040A (en) 1993-11-29
KR930019633A (ko) 1993-10-18
DE4208051A1 (de) 1993-09-16
EP0560163A1 (de) 1993-09-15

Similar Documents

Publication Publication Date Title
EP0597463A3 (en) Thermotherapiesonde.
EP0580285A3 (en) Auto-reclosers.
EP0633771A4 (en) Compounds.
ZA931773B (en) Substituted phenylacetamides.
EP0572808A3 (de) Antiblockierregelsystem.
DE59204008D1 (en) Trachealstent.
ZA926482B (en) Cyanophenylpyrroles.
ZA927792B (en) Anti-alpha6-integrin-antibodies.
EP0668864A4 (en) SUBSTITUTED BIPHENYLMETHYLIMIDAZOPYRIDINES.
ZA931772B (en) Imidazolyl-substituted phenylacetamides.
EP0599191A3 (en) Engine speed control circuit.
DE69205795D1 (en) Mesoprotheseunterlage.
EP0592354A3 (de) Vakuum-Zentrifuge.
DE69203865D1 (en) Thermo-transferdrucksystem.
DE69204801D1 (en) Hydroxy- oder oxosubstituierte alkylcyclopentene.
EP0663819A4 (en) IBUPROFEN-COFFEINE COMBINATIONS.
ZA925725B (en) Qinolin-2-yl-methoxybenzylhydroxyureas.
ZA933848B (en) Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides
EP0624089A4 (en) Methods.
ZA921865B (en) Isoxazole- and isothiazole-5-carboxamides.
ZA935828B (en) New insobutyl-substituted methanesulphonyl-quinolyl-methoxyphenyl-cycloalkylacetamides.
DE59200703D1 (en) Polyketomethinfarbstoffe.
PH30999A (en) Benzoquinoxalines.
GB9221450D0 (en) The wropod
GB2266530B (en) Substituted 1,1,2-triphenylbutenes